CVE-2026-0775npm cli Incorrect Permission Assignment Local Privilege Escalation Vulnerability.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
npm cli Incorrect Permission Assignment Local Privilege Escalation Vulnerability. This vulnerability allows local attackers to escalate privileges on affected installations of npm cli. An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability. The specific flaw exists within the handling of modules. The application loads modules from an unsecured location. An attacker can leverage this vulnerability to escalate privileges and execute arbitrary code in the context of a target user. Was ZDI-CAN-25430.
- CVSS
- 7.0 HIGH (v3.1, NVD)CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-732
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jul 15, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://www.zerodayinitiative.com/advisories/ZDI-26-043/
- https://access.redhat.com/security/cve/CVE-2026-0775
- https://bugzilla.redhat.com/show_bug.cgi?id=2432280
- https://security.access.redhat.com/data/csaf/v2/vex/2026/cve-2026-0775.json
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.